Nicholson, Andrew C.

Publications

Sort by

Co-Author Network

selected publications

Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. The American journal of pathology. 2009 Academic Article GET IT
Times cited: 27
Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. British journal of pharmacology. 2008 Academic Article GET IT
Times cited: 40
Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression. British journal of pharmacology. 2007 Academic Article GET IT
Times cited: 43
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation. 2004 Academic Article GET IT
Times cited: 52
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36. Circulation. 2004 Academic Article GET IT
Times cited: 77
CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. Vascular pharmacology. 2004 Review GET IT
Times cited: 69
Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. Trends in cardiovascular medicine. 2004 Review GET IT
Times cited: 92
Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. Journal of cellular biochemistry. 2003 Academic Article GET IT
Times cited: 45
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. Journal of lipid research. 2003 Academic Article GET IT
Times cited: 53
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. The Journal of biological chemistry. 2002 Academic Article GET IT
Times cited: 58
Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Annals of the New York Academy of Sciences. 2001 Review GET IT
Times cited: 112
Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. The Journal of biological chemistry. 2001 Academic Article GET IT
Times cited: 62
CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Annals of the New York Academy of Sciences. 2000 Review GET IT
Times cited: 64
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. Journal of lipid research. 2000 Academic Article GET IT
Times cited: 219
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. The Journal of biological chemistry. 2000 Academic Article GET IT
Times cited: 167
Viral activation of the coagulation cascade. American heart journal. 1999 Review GET IT
Times cited: 8
Herpesviruses and thrombosis: activation of coagulation on the endothelium. Clinica chimica acta; international journal of clinical chemistry. 1999 Review GET IT
Times cited: 22
Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36. Journal of lipid research. 1999 Academic Article GET IT
Times cited: 87
Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. The Journal of biological chemistry. 1998 Academic Article GET IT
Times cited: 53
Lipoproteins modulate expression of the macrophage scavenger receptor. The American journal of pathology. 1998 Academic Article GET IT
Times cited: 36
Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders?. Arteriosclerosis, thrombosis, and vascular biology. 1998 Review GET IT
Times cited: 93
Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. The Journal of biological chemistry. 1997 Academic Article GET IT
Times cited: 234
Viral activation of coagulation: implications for thrombosis and atherosclerosis. Annals of the New York Academy of Sciences. 1997 Review GET IT
Times cited: 5
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. The Journal of biological chemistry. 1996 Academic Article GET IT
Times cited: 76
Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. The Journal of biological chemistry. 1996 Academic Article GET IT
Times cited: 101
Altered cholesterol trafficking in herpesvirus-infected arterial cells. Evidence for viral protein kinase-mediated cholesterol accumulation. The Journal of biological chemistry. 1995 Academic Article GET IT
Times cited: 24
Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an acyl-CoA cholesterol acyltransferase inhibitor. Lipids. 1995 Academic Article GET IT
Times cited: 4
Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arteriosclerosis, thrombosis, and vascular biology. 1995 Academic Article GET IT
Times cited: 223
Signal transduction in atherosclerosis: second messengers and regulation of cellular cholesterol trafficking. Advances in experimental medicine and biology. 1995 Review GET IT
Times cited: 18
Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. The Journal of biological chemistry. 1994 Academic Article GET IT
Times cited: 27
Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. The Journal of biological chemistry. 1993 Academic Article GET IT
Times cited: 131
Developmentally regulated herpesvirus plaque formation in arterial smooth muscle cells. Circulation research. 1993 Academic Article GET IT
Times cited: 7
Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. The Journal of biological chemistry. 1993 Academic Article GET IT
Times cited: 113
Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. The Journal of biological chemistry. 1992 Academic Article GET IT
Times cited: 45
Dihydropyridine calcium antagonist modulates cholesterol metabolism and eicosanoid biosynthesis in vascular cells. Journal of cellular biochemistry. 1992 Academic Article GET IT
Times cited: 10
Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolase. Proceedings of the National Academy of Sciences of the United States of America. 1989 Academic Article GET IT
Times cited: 11
Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. The Journal of experimental medicine. 1988 Academic Article GET IT
Times cited: 89

more ...

less ...

Background

education and training

Ph.D., Cornell University 1992
D.V.M., Michigan State University 1976
B.S., Michigan State University 1973

Contact

full name

Andrew C. Nicholson

primary email

nicholso@med.cornell.edu

VIVO Weill Cornell Medical College

Andrew C. Nicholson Associate Professor of Research in Comparative Pathology and Laboratory Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email